News
15h
Stockhead on MSNNew Prescient leadership to drive PTX-100 development in rare blood cancerWith a new leadership team and fast-track designation from the US Food and Drug Administration (FDA), clinical-stage oncology ...
Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...
Every three minutes, about one person is diagnosed with a form of blood cancer for which the treatment could require a bone ...
A “MOLECULAR shield” placed in the nose could prevent hay fever symptoms, a study suggests. Scientists have engineered an ...
Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 million school- and workdays ...
During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that causes AIDS. He co-founded the field of paleovirology and considers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results